Pancreatic ductal adenocarcinoma (PDAC) reportedly progresses very rapidly through the initial carcinogenesis stages including DNA damage and disordered cell death. However, such oncogenic mechanisms are largely studied through observational diagnostic methods, partly because of a lack of live in vitro tumour imaging techniques. Here we demonstrate a simple live-tumour in vitro imaging technique using micro-patterned plates (micro/nanoplates) that allows dynamic visualisation of PDAC microtumours. When PDAC cells were cultured on a micro/nanoplate overnight, the cells self-organised into non-spheroidal microtumours that were anchored to the micro/nanoplate through cell-in-cell invasion. This self-organisation was only efficiently induced in small-diameter rough microislands. Using a time-lapse imaging system, we found that PDAC microtumours actively stretched to catch dead cell debris via filo/lamellipoedia and suction, suggesting that they have a sophisticated survival strategy (analogous to that of starving animals), which implies a context for the development of possible therapies for PDACs. The simple tumour imaging system visualises a potential of PDAC cells, in which the aggressive tumour dynamics reminds us of the need to review traditional PDAC pathogenesis.
Despite accumulating evidence on the pathological features exhibited by cancer cells in various carcinomas, recent in vitro cancer cell studies have focused on the behavior of single cells in isolation. In contrast, in analyses conducted at the tumor tissue level, in vivo methodologies still largely depend on observational diagnostic methods such as histopathological analysis and in vivo imaging systems using fluorescent imaging probes. Consequently, the underlying pathophysiological tumor dynamics in tissue remains mostly unclear. Thus, in current cancer research, directly linking in vitro cell-based studies with in vivo tissue-based pathological studies could result in a huge gap in our understanding. Indeed, we have been confronted with numerous unexpected difficulties in clinical trials of molecular-targeted anticancer agents for which there should be near perfect evidence for targets from conventional evaluations undertaken both in vivo and in vitro. Recently, the importance of using three-dimensional (3D) cell culture systems has remarkably increased in the field of anticancer drug development1,2,3,4; 3D cell culture systems are expected to provide more physiologically relevant information to the in vivo setting as compared with traditional two-dimensional culture systems5,6,7,8.
PDAC, which constitutes approximately 90% of pancreatic cancers, is still one of the most lethal malignant tumours9. KRAS mutation is the initiating genetic event for pancreatic intraepithelial neoplasia (PanINs), premalignant lesions of PDACs10. Recent work has shown that once PDACs become detectable, they progress from T1 stage to T4 stage in approximately 14 months11. PDACs rapidly progress through highly frequent DNA damage and mitotic abnormalities through unknown catastrophic events12,13. Generally, the epithelial–mesenchymal transition (EMT) is believed to be one of the essential events for the acquisition of metastatic ability in a variety of carcinomas14,15,16,17,18. However, a recent study using genetically engineered mouse models of PDAC development reported that carcinoma cells could metastasise without activating EMT programs19,20. And while the extremely aggressiveness characteristics of PDACs are well established, the dynamics of PDAC tumours have not been well studied.
In this study, we developed a new type of cell culture micro/nanoplate, which elicits the ability of carcinoma cells to self-organise through the addition of a simple modification by micro-nanotechnology. We demonstrate here that anchorage-dependent PDAC microtumours on the micro/nanoplate show morphological polarity and exhibit active motility through filipoedia and lamellipoedia. Furthermore, the micro/nanoplate enables visualisation of live tumour dynamics; the microtumours endocytose debris-derived surface nucleosides directly into vacuoles and then accumulate dead cell-derived phosphatidylserine (PS) on their surfaces (resulting in PS externalisation, a cause of cancer immune evasion). Hence, the tumour dynamics visualised by our simple technology urge us to review the well-known pathogenesis of this intractable cancer and will contribute to the development of innovative new anticancer drugs.
Materials and Methods
Reagents and antibodies
We used 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer for glass (PC modifier-C, Daiichi Kigyo, Japan), Parylene-C (Specialty Coating Systems, USA) and positive photoresist (PR; S1818 Shipley, USA) for preparation of the micro/nanoplate. Mouse anti-human α-tubulin (clone DM1A, eBioscience), mouse anti-human dynein intermediate chain 1 (Abcam, Cambridge, UK) monoclonal antibodies (mAbs) were used for immunofluorescence staining. 5- (and 6-) carboxyfluorescein diacetate succinimidyl ester (CFSE; Dojindo Laboratories, Kumamoto, Japan), and PKH26 (Sigma-Aldrich, St. Louis, MO, USA) were used for live-cell labelling. Annexin V Alexa Flour® 488 (Molecular Probes, Inc., Eugene, OR, USA) and Ethidium Homodimer-1 (EthD-1; Molecular Probes, Inc.) were used for live and dead cell monitoring. Cell Navigator™ Lysosome Staining Kit Red Fluorescence (AAT Bioquest, Inc., Sunnyvale, CA, USA) was used for lysosome staining. FluoSpheres® Carboxylate-Modified Microspheres (0.2 µm, yellow-green fluorescent; Molecular Probes, Inc.) were used to track the flow of medium. Click-iT® Plus EdU (5-ethynyl-2′-deoxyuridine, a nucleoside analogue of thymidine) Alexa Fluor® 594 Imaging Kits (Molecular Probes, Inc.) were used to detect nucleosides. Nocodazole (Sigma-Aldrich) was used as a microtubule inhibitor. Formalin-fixed tissue sections were subjected to immunohistochemical staining using the LSAB2 Kit/HRP (Dako, Glostrup, Denmark).
Three human PDAC lines, PCI-55, PCI-24, and PCI-43, were used. These cell lines were established in our laboratory from PDAC tissues that were resected from primary sites at Hokkaido University Hospital21. LH Gene Mutation Detection Kit for KRAS Mutation Codons 12 and 13 (Wako, Osaka, Japan) was used for detection of KRAS mutation in these cell lines. Human oral squamous carcinoma cell lines, HSC-3 and SCC-9, lung adenocarcinoma cell lines, H1975 and A549, and colon adenocarcinoma cell lines, DLD-1 and WiDr, were purchased from JCRB cell bank (Osaka, Japan) and ATCC. KHYG-1, a human NK cell line, was purchased from JCRB and maintained in RPMI-1640, supplemented with 100 U of recombinant human IL-2 (Shionogi, Osaka, Japan), 10% FBS, and penicillin/streptomycin.
Preparation of the micro/nanoplate
In this research, we modified our previous patterning method22. The first step was forming 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer layer on a glass substrate23. We spun the MPC solution at 2000 rpm for 30 sec and then dried the substrate in a chamber with an ethanol atmosphere at room temperature for 20 min to form the polymer layer uniformly. Finally, the substrate was baked at 70 °C for 4 h to graft the MPC polymer covalently to the substrate by a dehydration reaction. We then deposited a 1-µm-thick poly(p-xylylene) (Parylene-C) dry film mask onto the MPC-grafted layer. Parylene forms a thin, flexible and transparent film when deposited by chemical vapour deposition with a Parylene deposition machine (Labcoter PDS2010, Specialty Coating Systems, USA). The deposition process consists of three steps: dimer (di-p-xylene) vaporization at approximately 150 °C, monomerization at 690 °C, and finally polymerization at room temperature. Next, a photoresist (PR) was patterned on the Parylene film using a standard photolithographic technique to define etching regions for both the Parylene film and MPC polymer. The PR was then spin-coated onto the substrate. After exposure to ultraviolet light through a glass mask (SUSS Micro Tes: MA-6, Germany), the PR was developed using NMD-3 (2.38% Tetramethyl Ammonium Hydroxide) developer. Both the Parylene film and MPC polymer were then etched away with O2 plasma (50 W for 4.5 min) at the defined regions using inductively coupled plasma etching system (EIS-700, ELIONIX INC, Tokyo, Japan). Roughness was measured using VK-X250 3D Laser Scanning Confocal Microscope (Keyence Corporation, Osaka, Japan).
Cell culture using the micro/nanoplate
The prepared micro/nanoplate has cell-adherable micro-circular islands, 30 µm in diameter, with nanoscale roughness. These patterned micro-circular islands with nanoscale roughness were glass substrates, which allowed cells to adhere; the rest was coated with MPC polymer, which inhibits protein adsorption and cell adhesion. The Parylene layer was gently peeled off, washed with distilled water once and sterilized with 70% ethanol for 10 min and dried in the clean bench. A small amount of petroleum jelly was applied at the four corners of a 40 mm petri dish and the 20 mm × 20 mm micro/nanoplate was then fixed on them. The micro/nanoplate fixed in the petri dish was washed three times with medium and soaked in the medium until cell culture to avoid drying. We suspended 1–3 × 106 PDAC cells in 3 ml of 10% FBS DMEM, gently poured this cell suspension on the micro/nanoplate fixed in the petri dish before incubation at 37 °C in a CO2 incubator. After overnight culture, anchorage-dependent PDAC microtumours self-organized on the micro/nanoplate and were used for subsequent experiments. To inhibit microtubules, anchorage-dependent PDAC microtumours were treated for indicated times with 1 µM nocodazole. Some plates received fresh medium without nocodazole by washing with PBS for 3 times.
We purchased C.B-17/lcr-scid/scidJcl mice from CLEA Japan, Inc. (Tokyo, Japan). These mice (severe combined immunodeficiency [SCID] mice) were bred and housed under specific pathogen-free conditions in our animal facility. Animal experiments were conducted according to the Guidelines for the Care and Use of Laboratory Animals at Hokkaido University Faculty of Medicine and approved by the Institutional Review Committee of Hokkaido University.
Intraperitoneal injection of PDAC cells
Male SCID mice (6–8 weeks old) were injected intraperitoneally with a mixture of CFSE- or unlabelled PCI-55 (total 5 × 106 cells) suspended in 200 µl of PBS. Peritonea were harvested at 3 days after injection and prepared for frozen sections with Tissue-Tek O.C.T. Compound (Sakura Finetek Japan, Tokyo, Japan).
Microtumours anchored to the micro/nanoplates were fixed with 4% paraformaldehyde for 20 min. For intracellular staining, cells were treated with PBS that contained 0.5% Triton-X-100 for 20 min and then fixed with ice-cold 70% methanol for 5 min. Nonspecific binding was blocked with PBT (0.05% Tween-20 in PBS) that contained 0.1% goat serum for 10 min. After incubation with primary Abs for each targeted protein, Alexa Fluor-conjugated goat polyclonal Ab was used as a secondary Ab. Time-lapse images and high resolution two-dimensional (2D) images were acquired by inverted fluorescence microscope (Keyence BZ-X700 and BZ-9000; Keyence Corporation). Three-dimensional (3D) analyses were reconstructed by images acquired by a spectral imaging confocal microscope (Nikon-A1R; Nikon Instech Co., Ltd., Tokyo, Japan) using NIS-Elements AR Ver 4.60.00 software (Nikon).
In this study, we enlisted 10 patients with histologically confirmed PDAC, whose tumours were surgically resected at Hokkaido Gastroenterology Hospital (Sapporo, Japan). All experiments using human specimens were approved by the Medical Ethics Committees of Hokkaido University Faculty of Medicine. Three-µm-thick human aorta sections were deparaffinized and antigen-retrieved by autoclaving at 121 °C for 20 min. Nonspecific binding was blocked with 3% goat serum in PBS for 30 min. To prevent endogenous peroxidase activity, sections were incubated in 3% hydrogen peroxide for 10 min. Sections were incubated with primary Ab for 1 h at room temperature, then with biotinylated secondary Ab and finally with streptavidin-HRP (LSAB2 kit; Dako). After incubation, specimens were developed with diaminobenzidine (Dako) and counterstained with Mayer’s haematoxylin.
Live and dead cell assay
Anchorage-dependent PDAC microtumours on the micro/nanoplate in the petri dish were cultured in 3 ml of DMEM culture medium supplemented with Annexin V Alexa Flour 488 (25 µl) and EthD-1 (2 µm). Time-lapse images were captured using an inverted fluorescence microscope (Keyence BZ-X700 and BZ-9000).
PCI-55 cells were cultured in 60-mm tissue culture dishes overnight. After washing with PBS 2 times, PCI-55 cells were UV-irradiated at 250 mJ/cm2 with Bio-Rad GS Gene Linker (Bio-Rad, San Jose, CA). After washing with PBS again, they were incubated with serum-free DMEM for 2 h. Dead PCI-55 cells and debris were harvested by a cell scraper and used for dead cell feeding.
PDAC cells (5 × 105) were cultured in 60-mm tissue culture dishes in medium containing 10 µM EdU for 24 h. Cells were then fixed in 4% paraformaldehyde in PBS with 0.05% Tween-20 for 20 min at room temperature, and them permeabilized in 0.5% Triton X-100 for 20 min. The EdU was then detected by following manufacturer’s instructions of the Click-iT EdU imaging Kits (Invitrogen), using Alexa Fluor® 555.
Data were analysed using Student’s t-test. P < 0.05 was considered significant.
PDAC cells self-organise into non-spherical microtumours anchored to the micro/nanoplate
To visualise live tumours and their dynamics, we devised a novel in vitro tumour imaging system using micro-patterned plates (micro/nanoplates) prepared according to a standard photolithography method22 (Fig. 1a). Specifically, we coated a glass substrate with MPC polymer, grafted the MPC polymer, deposited Parylene film onto the MPC polymer, and then deposited and patterned the photoresist (PR). These patterned plates were etched with both the Parylene and MPC polymer using oxygen (O2) plasma, and then the PR was removed before use (Fig. 1b). Using laser scanning microscopy, we performed quantitative analysis of the plate roughness. Arithmetical mean height (Ra), maximum height of profile (Rz) and arithmetic mean peak curvature (Spc) in the patterned circular islands with roughness (micro/nanoplate) were about twice that of conventional microplates, developed interfacial area ratio (Sdr) were about 4.8 times (Fig. 1c,d). These results indicated that the patterned circular islands in the micro/nanoplate had nano-scale roughness slightly higher than conventional microplates. To culture cancer cells using the micro/nanoplate, we employed three human PDAC cell lines (PCI-55, PCI-24, and PCI-43) with heterozygous KRASG12D mutation, the most common mutation in clinical PDAC24,25. When PDAC cells were cultured in micro/nanoplates overnight, they self-organised into three-dimensional (3D) non-spherical microtumours that were solidly anchored to multiple microislands across the plates’ non-adherable areas (Figs 1e, 2a,b and Supplementary Movie 1). When other carcinoma cell lines such as oral cancer, lung cancer and colon cancer cell lines were cultured, they self-organised into variously-shaped microtumours on the micro/nanoplate (Fig. 2c). This self-organisation was only efficiently induced in rough (i.e., adherable), small-diameter microislands (Figs 1e,g,h and 3a–c). When PDAC microtumours exceeded the bottom area size of a micro-island, the circularity of microtumours decreased sharply (r2 = 0.5271; Fig. 1f), exhibiting invasive expansion. Our 3D images clearly showed that PDAC microtumours anchored to multiple microislands had morphological polarity (Fig. 3d–f and Supplementary Movie 2). When anchorage-dependent PDAC microtumours exceeded their single microislands, they exhibited microtubules (MT)-based protrusions in the presumed direction of movement (Fig. 3g,h).
PDAC microtumours are triggered by a cell-in-cell structure anchored to a micro-island
Next, we investigated how self-organisation of anchorage-dependent PDAC microtumours was triggered on the micro/nanoplate. Time-lapse images showed that at least nine PCI-55 cells were anchored to a micro-island through entosis (cell-in-cell invasion; Fig. 4a, Supplementary Movie 3)26,27. Surprisingly, this entotic event was reversible and did not involve cell death (Fig. 4b, Supplementary Movie 4). Therefore, it was different from the entotic event often observed in carcinoma specimens where most internalized cells are eventually killed28. When PCI-55 cells were sparsely cultured, a few cells showed live cell entosis in microislands (Fig. 4c) and at least four cells formed papillary cell-in-cell structures (Fig. 4d). Our 3D images showed a CFSEHigh-labelled PCI-55 cell penetrating into CFSELow-labelled cells that formed a microtumour (Fig. 4e). Similarly, multinucleated giant PCI-55 cells whose green fluorescence intensity was almost halved contained at least six CFSEHigh-labelled PCI-55 cells (Fig. 4f); other PDAC cell lines also self-organised into cell-in-cell structures on the micro/nanoplate (data not shown). We also found PDAC microtumours anchored to single microislands to form MTs and actin filaments vigorously near the anchored parts (Fig. 4g), suggesting the possibility that the micro/nanoplate may induce differentiation into mature microtumours. Taken together, these results indicate that self-organisation of PDAC microtumours is triggered by cell-in-cell structures anchored to rough microislands.
Cells covering the surface of PDAC microtumours exhibit peri-membranous expression of α-tubulin
In 3D cultures, α-tubulin is expressed in the peripheral regions of spheroids29. Our results also indicated that PDAC microtumours were covered by cells exhibiting enhanced peri-membranous expression of α-tubulin (Fig. 4c–g). However, such peri-membranous expression of α-tubulin was not observed in mitotic cells that were located outside the surface of the microtumours (Fig. 4h,i). MT inhibitors are shown to be anticancer agents that target mitosis30. Nocodazole, an inhibitor of MT polymerisation, prevented PCI-55 microtumours from anchoring to the micro/nanoplate (Fig. 4j, Supplementary Movie 5). Most of the treated microtumours showed anchorage-independent spheroidal morphology, and many live PCI-55 cells were scattered outside of the disrupted microtumours (Fig. 4k). However, the disruption did not induce cell death even in scattered cells (Fig. 4l, Supplementary Movie 6). Furthermore, when PCI-55 cells were grafted intraperitoneally into SCID mice, similar peri-membranous expression of α-tubulin was also observed in PCI-55 microtumours that colonized in the peritoneum in vivo (Fig. 4m). These results suggest that MTs composed of α-tubulin are involved in the formation of anchorage-dependent PDAC microtumours. MT inhibitors are shown to be anticancer agents that target mitosis30. Next, we examined whether such peri-membranous expression of α-tubulin is a clinically relevant phenomenon. As expected, similar expression patterns and cell-in-cell structures formed by both live cells and dead cells were observed in PanIN lesions and invasive PDACs but not in normal pancreatic ductal epithelium (Fig. 5a–e). In 9 out of 11 PDAC specimens, we observed cell-in-cell structures within live cells (Fig. 5e, arrow heads) more frequently than within dead cells (Fig. 5e, arrows). Particularly, peri-membranous expression of α-tubulin was greater in higher grade PanIN lesions and invasive PDACs (Fig. 5d,e). Taken together, these results suggest that PDAC microtumours anchored to the micro/nanoplate mimic microscopic tumour lesions observed in human clinical PDAC specimens.
Live anchorage-dependent PDAC microtumours catch dead-cell debris and display the death phenotype
We found that anchorage-dependent PDAC microtumours on the micro/nanoplate integrally formed huge lamellipoedia (Fig. 6a), and the morphological polarity covered by membranous α-tubulin expression was very close to that of single cells (Fig. 6b). Thus, we next examined whether anchorage-dependent PDAC microtumours behave as single units. Time-lapse images showed live PCI-55 microtumours actively moving to catch debris in culture medium (Fig. 6c, Supplementary Movie 7). To examine whether live PDAC microtumours actively take in dead-cell debris, we used live- and dead-cell monitoring, using Annexin V (green) and EthD-1 (red)31. Time-lapse images showed live PCI-55 microtumours stretching to catch external floating apoptotic cells and dead-cell debris with huge lamellipoedia (Fig. 6d, Supplementary Movie 8).
Live PDAC microtumours secondarily show PS externalisation by sucking and catching dead-cell debris
Interestingly, before the debris was taken up by the PCI-55 microtumours, it accumulated in front of the microtumours, suggesting that PDAC microtumours suck and then catch debris (Fig. 6c). Indeed, we confirmed that in cultured medium, many floating green-fluorescent nanobeads drifted towards anchorage-dependent PCI-55 microtumours, which suggests that live PDAC microtumours have a strong suction force on their surface (Fig. 6g, Supplementary Movie 9). Consistent with this, we frequently observed that PDAC microtumours accumulated Annexin V on their external surfaces (Fig. 6e). Even when microtumour-forming PDAC cells were in a mitotic phase they were covered by the strong green fluorescence of Annexin V (Fig. 6f). When anchorage-dependent PCI-55 microtumours were harvested and cultured back in a culture dish, they stopped elongation and began removing PS from their surfaces (Fig. 6h, Supplementary Movie 10). Additionally, we confirmed that when PCI-55 microtumours were cocultured with KHYG-1, a human natural killer (NK) cell line, they were not attacked by KHYG-1 cells, suggesting that live PDAC microtumours might be misrecognised as non-viable tissue by immune cells (Fig. 6i,j, Supplementary Movie 11).
Live PDAC microtumours feed on dead-cell debris
Live imaging analysis using micro/nanoplates demonstrated that annexin V+/EthD-1+ live PDAC microtumours accumulated Annexin V on their external surfaces, whereas EthD-1 accumulated inside the cells (Fig. 7a,b, Supplementary Movie 12). Finally, we performed PDAC microtumour-feeding with their dead cell debris. Live PCI-55 microtumours treated with UV produced dead-cell debris (Fig. 7c). The microtumours took up this dead-cell debris, and began to display red EthD-1 fluorescence from their outer edges (Fig. 7d). Mature microtumours aggressively devoured dead-cell debris (Fig. 7e, Supplementary Movie 13). Consistent with this, PCI-55 microtumours significantly increased in size at 48 h after feeding on dead-cell debris compared with microtumours that did not feed (Fig. 7f). The cell death mechanism reportedly promotes PDAC tumour growth13, and our results suggest that external dead cell debris contributes to PDAC tumour growth as well. Our results also suggest that PDAC microtumours take in nuclear components, such as EthD-1 (which has a high affinity for nucleic acid), indicating that the increased autophagy and lysosomal catabolism extended to nuclear fragments32. Next, to find whether PDAC microtumours directly take in dead cell-derived nucleosides from their surfaces, we fed CFSE-labelled PCI-55 microtumours with UV-induced dead PCI-55 cells that had previously incorporated a nucleoside analogue of thymidine, Edu. As expected, we observed massive accumulation of Edu+ dead-cell debris around the microtumours (Fig. 7g). Cross-sectional images showed considerable Edu in microtumour vacuoles (Fig. 7h); some Edu was detected in lysosomes (Fig. 7i), indicating that Edu + dead-cell debris was endocytosed from the surface of the PDAC microtumour and then incorporated into lysosomes of the inner cells forming the microtumours. These results suggest direct recycling of external dead-cell debris-derived nucleotides by PDAC microtumours.
In this study, we developed a micro/nanoplate that promotes self-organisation in PDAC cells by micro-nanotechnology (Figs 1 and 2). We have demonstrated that anchorage-dependent PDAC microtumours on the micro/nanoplate show morphological polarity and aggressive motility (Fig. 3). Self-organisation of PDAC microtumours was triggered by cell-in-cell structures anchored to rough microislands (Fig. 4). Cellular internalization process entosis frequently observed in human tumours is known as a mechanism underlying the cancer cell competition, cell-in-cell structure or cannibalism26,27,33. Very limited cell-adherable microislands on the micro/nanoplate provide states susceptible to induce entosis to PDAC cells. It may be very similar to the malignant tumour lesion of PDAC showing abnormal multilayer proliferation in very restricted parts of the lumen of the pancreatic duct.
We also found that PDAC microtumours were covered by enhanced peri-membranous expression of α-tubulin both in vitro and in vivo (Figs 4 and 5). MT inhibitors are shown to be anticancer agents that target mitosis30,34,35. Our results showed that most of the MT-treated microtumours showed anchorage-independent spheroidal morphology, and many PCI-55 cells were scattered outside of the disrupted microtumours and were not dead (Fig. 4). Thus, these results suggest that the disruption of PDAC microtumours without cell death may be a side effect of MT inhibitors as anticancer agents, leading to scattering of living cancer cells and then recurrence.
Furthermore, we have demonstrated that the micro/nanoplate enables visualisation of live tumour dynamics, revealing that the microtumours endocytose debris-derived surface nucleosides directly into vacuoles and then accumulate dead-cell-derived phosphatidylserine (PS) on their surfaces (Figs 6 and 7). Externalisation of PS is an important well-known feature in cancer cells and has shown to be a cause of immune evasion in cancer36,37,38,39, but how it occurs in tumours is unclear. We found that live PDAC microtumours secondarily show PS externalisation by sucking and catching dead-cell debris. Our findings imply that PS externalisation might occur on live PDAC microtumour surfaces as a result of dead-cell debris absorption. At the present time, we do not have the technology to understand the phenomenon both in vitro and in vivo. This simple tumour imaging system will enable us to visualise more of the true nature of live PDAC microtumours; the observed tumour dynamics would urge us to review the traditional understanding of PDAC pathogenesis.
In this study, we also observed that nocodazole-inhibited MTs decreased externalisation of PS in the PDAC microtumours on the micro/nanoplate (Fig. 4). This result indicates that MT-inhibited PDAC microtumours stop exhibiting the apoptotic phenotype. Immune cells recognised PS-externalized PDAC microtumours as dead tissues, which may result in cancer immune evasion. Perhaps our results imply the possibility that MT-inhibitors may be useful for removing the secondary dead-cell phenotype in the PDAC microtumours to enhance cancer immunotherapy.
Our work has demonstrated that mature microtumours advanced like starving animals exhibited cannibalism to survive. It is most likely to occur in PDAC patients, but currently there are only approaches to deduce it in fixed samples in vivo. Consideration of this sophisticated survival strategy in malignant epithelial cells and inhibiting or exploiting the relevant pathophysiological events could lead to genuine therapeutic options against this intractable cancer. This simple, low-cost in vitro tumour imaging system could bridge the gap between cell-based and tissue-based analyses, leading to a better understanding of PDAC progression from cancer cells to microtumours.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rocha Lima, C. M. et al. Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol 22, 3776–3783, https://doi.org/10.1200/JCO.2004.12.082 (2004).
Wendt, D., Riboldi, S. A., Cioffi, M. & Martin, I. Potential and bottlenecks of bioreactors in 3D cell culture and tissue manufacturing. Adv Mater 21, 3352–3367, https://doi.org/10.1002/adma.200802748 (2009).
Caliari, S. R. & Burdick, J. A. A practical guide to hydrogels for cell culture. Nat Methods 13, 405–414, https://doi.org/10.1038/nmeth.3839 (2016).
Gjorevski, N. et al. Designer matrices for intestinal stem cell and organoid culture. Nature 539, 560–564, https://doi.org/10.1038/nature20168 (2016).
Pampaloni, F., Reynaud, E. G. & Stelzer, E. H. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839–845, https://doi.org/10.1038/nrm2236 (2007).
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M. & Krek, W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69-70, 29–41, https://doi.org/10.1016/j.addr.2014.03.001 (2014).
Ranga, A., Gjorevski, N. & Lutolf, M. P. Drug discovery through stem cell-based organoid models. Adv Drug Deliv Rev 69-70, 19–28, https://doi.org/10.1016/j.addr.2014.02.006 (2014).
Weigelt, B., Ghajar, C. M. & Bissell, M. J. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv Drug Deliv Rev 69-70, 42–51, https://doi.org/10.1016/j.addr.2014.01.001 (2014).
Li, D., Xie, K., Wolff, R. & Abbruzzese, J. L. Pancreatic cancer. Lancet 363, 1049–1057, https://doi.org/10.1016/S0140-6736(04)15841-8 (2004).
Waddell, N. et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518, 495–501, https://doi.org/10.1038/nature14169 (2015).
Yu, J., Blackford, A. L., Dal Molin, M., Wolfgang, C. L. & Goggins, M. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut 64, 1783–1789, https://doi.org/10.1136/gutjnl-2014-308653 (2015).
Notta, F. et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 378–382, https://doi.org/10.1038/nature19823 (2016).
Seifert, L. et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532, 245–249, https://doi.org/10.1038/nature17403 (2016).
Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361, https://doi.org/10.1016/j.cell.2011.11.025 (2012).
Wang, Z. et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 69, 2400–2407, https://doi.org/10.1158/0008-5472.CAN-08-4312 (2009).
Arumugam, T. et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69, 5820–5828, https://doi.org/10.1158/0008-5472.CAN-08-2819 (2009).
Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715, https://doi.org/10.1016/j.cell.2008.03.027 (2008).
Acloque, H., Adams, M. S., Fishwick, K., Bronner-Fraser, M. & Nieto, M. A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119, 1438–1449, https://doi.org/10.1172/JCI38019 (2009).
Aiello, N. M. et al. Upholding a role for EMT in pancreatic cancer metastasis. Nature 547, E7–E8, https://doi.org/10.1038/nature22963 (2017).
Zheng, X. et al. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525–530, https://doi.org/10.1038/nature16064 (2015).
Kishimoto, T. et al. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer 69, 290–294, https://doi.org/10.1002/(SICI)1097-0215 (1996).
Kuribayashi, K., Tsuda, Y., Nakamura, H. & Takeuchi, S. Micro-patterning of phosphorylcholine-based polymers in a microfluidic channel. Sensors and Actuators B: Chemical 149, 177–183 (2010).
Ishihara, K., Aragaki, R., Ueda, T., Watenabe, A. & Nakabayashi, N. Reduced thrombogenicity of polymers having phospholipid polar groups. J Biomed Mater Res 24, 1069–1077, https://doi.org/10.1002/jbm.820240809 (1990).
Ying, H. et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656–670, https://doi.org/10.1016/j.cell.2012.01.058 (2012).
Kiuchi, S., Ikeshita, S., Miyatake, Y. & Kasahara, M. Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis. Exp Mol Pathol 98, 41–46, https://doi.org/10.1016/j.yexmp.2014.12.001 (2015).
Overholtzer, M. et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131, 966–979, https://doi.org/10.1016/j.cell.2007.10.040 (2007).
Kroemer, G. & Perfettini, J. L. Entosis, a key player in cancer cell competition. Cell Res 24, 1280–1281, https://doi.org/10.1038/cr.2014.133 (2014).
Hamann, J. C. et al. Entosis Is Induced by Glucose Starvation. Cell Rep 20, 201–210, https://doi.org/10.1016/j.celrep.2017.06.037 (2017).
Matsuda, Y. et al. Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods. Int J Oncol 38, 1253–1258, https://doi.org/10.3892/ijo.2011.945 (2011).
Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4, 253–265, https://doi.org/10.1038/nrc1317 (2004).
Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin. V. J Immunol Methods 184, 39–51 (1995).
Perera, R. M. et al. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524, 361–365, https://doi.org/10.1038/nature14587 (2015).
Le Bot, N. Entosis: cell death by invasion. Nat Cell Biol 9, 1346, https://doi.org/10.1038/ncb1207-1346 (2007).
Dobbelstein, M. & Moll, U. Targeting tumour-supportive cellular machineries in anticancer drug development. Nat Rev Drug Discov 13, 179–196, https://doi.org/10.1038/nrd4201 (2014).
Poruchynsky, M. S. et al. Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins. Proc Natl Acad Sci USA 112, 1571–1576, https://doi.org/10.1073/pnas.1416418112 (2015).
Balasubramanian, K., Mirnikjoo, B. & Schroit, A. J. Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 282, 18357–18364, https://doi.org/10.1074/jbc.M700202200 (2007).
Birge, R. B. et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ 23, 962–978, https://doi.org/10.1038/cdd.2016.11 (2016).
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D. & Fidler, I. J. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51, 3062–3066 (1991).
Lima, L. G., Chammas, R., Monteiro, R. Q., Moreira, M. E. & Barcinski, M. A. Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283, 168–175, https://doi.org/10.1016/j.canlet.2009.03.041 (2009).
We thank K. Nakahata, Y. Higashi, T. Emoto, K. Ito, M. Susa, M. Sato, Y. Onodera, M. Kino and A. Honma for help in the development of the micro/nanoplate; T. Nemoto and K. Kobayashi for help with analysis of bioimaging at Nikon Imaging Center at Hokkaido University in ABiS, MEXT, Japan. This work was supported by JSPS KAKENHI Grant Number 26460464, JP16H06280, and NPJ Grant Number NPS15058 by Nanotechnology Platform of MEXT, Japan.